The state of Louisiana has brought a lawsuit against Pfizer, makers of the bestselling antidepressant drug Zoloft, claiming the company engaged in grossly fraudulent marketing by paying prominent medical researchers to publish articles written by Pfizer, praising Zoloft. Courthouse News reports that Attorney General Buddy … Full Story
Zoloft® is an antidepressant drug belonging to the SSRI class. These drugs manipulate the levels of serotonin in the brain, and are the most prescribed antidepressants in the US.
Depression no longer carries the stigma it once did. The number of people diagnosed with depression since the 1980s has tripled, also due in part to education and public awareness.
Everywhere you look, there are advertisements for antidepressants, including Zoloft®, Prozac, and Paxil, which have become common names to most people. Thus, the competition between drug companies to gain an edge over their competitors has also increased.
Through the 1990s, more than half the drug company studies on antidepressants showed they were no better than a sugar pill. In 1998, a scientist at Pfizer, maker of Zoloft®, found that "all SSRIs have the rare potential to cause akathisia." When referring to the most extreme cases, the scientist wrote that the patients might feel "death is a welcome result". The Zoloft® and other antidepressant drug controversy have escalated into a legal battle. Zoloft® lawsuits and other SSRI related lawsuits have continued to be argued.
February 2, 2004, an FDA advisory committee will hold yet another hearing regarding the risk of suicide by people taking antidepressants, like Zoloft®. For many families, the battle against antidepressant drug companies has been frustrating, especially since the February 2, 2004 hearing will be 13 years after the 1991 Prozac hearings first convened to discuss violence and suicide reports.
For more information on Zoloft®, please contact us to speak with a lawyer.